- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Dyslipidemia/Glucose Metabolism Disorder
Total 37617 results
-
GlaxoSmithKlineCompletedDyslipidaemia | DyslipidaemiasGermany, Estonia, Belgium, France, Netherlands, Denmark, Portugal, Norway, Sweden, Lithuania, Finland
-
GlaxoSmithKlineCompletedHealthy Subjects | Dyslipidaemia | DyslipidaemiasUnited Kingdom
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)CompletedInsulin Resistance | DyslipidaemiaCanada
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderCzech Republic, France, Hungary, India, Lithuania, Poland, Slovakia
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderFrance
-
Xention LtdCompleted
-
AstraZenecaCompletedDyslipidaemiaCzech Republic
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedDyslipidaemiaJordan, United States, Taiwan
-
GlaxoSmithKlineCompletedDyslipidemias | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedDyslipidaemiasUnited States, Canada
-
GlaxoSmithKlineCompleted
-
Novo Nordisk A/SRecruitingHealthy Volunteers | DyslipidaemiaUnited States
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
AstraZenecaCompletedDyslipidaemiaRussian Federation
-
Xention LtdCompleted
-
AstraZenecaCompletedHypercholesterolemia | Dyslipidaemia
-
Solvay PharmaceuticalsTerminatedDyslipidemia | Glucose Metabolism DisorderPoland, Croatia, Finland, France, Germany, Netherlands, Romania, Ukraine
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
Tufts UniversityCompletedDyslipidemia | Impaired Glucose Tolerance
-
AstraZenecaCompletedFredrickson Type IIa & Type IIb Dyslipidaemia
-
GWT-TUD GmbHTechnische Universität Dresden; University of RegensburgCompletedMetabolic Syndrome | DyslipidaemiaGermany
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
Leiden University Medical CenterDutch Diabetes Research FoundationCompletedInsulin Resistance | DyslipidemiaNetherlands
-
Leiden University Medical CenterDutch Diabetes Research FoundationCompletedInsulin Resistance | DyslipidemiaNetherlands
-
Radiant ResearchCompletedHyperglycemia | Dyslipidemia | HyperlipidemiaUnited States
-
UCSF Benioff Children's Hospital OaklandNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHealthy | Cardiovascular Disease | Insulin Resistance | Atherogenic DyslipidemiaUnited States
-
Heart Health Research CenterAstraZenecaNot yet recruitingMetabolism Disorder, Glucose | Metabolism Disorder, Lipid
-
Merck Sharp & Dohme LLCTerminatedMetabolic X Syndrome Dyslipidemia
-
Oklahoma State UniversityCompletedMetabolic Syndrome | DyslipidemiasUnited States
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI)CompletedMetabolic Syndrome | Insulin Resistance | DyslipidemiaUnited States
-
AstraZenecaCompletedMetabolic Syndrome | DyslipidemiaAustralia
-
University of NottinghamFlorida Department of CitrusCompletedObesity | Insulin Resistance | DyslipidemiaUnited Kingdom
-
GlaxoSmithKlineCompletedHealthy Subjects | DyslipidaemiasUnited States
-
Public Health Foundation of IndiaNational Heart, Lung, and Blood Institute (NHLBI); All India Institute of Medical... and other collaboratorsUnknownHypertension | Type 2 Diabetes Mellitus | DyslipidaemiaIndia, Pakistan
-
University of California, DavisUniversity of California, San Francisco; USDA, Western Human Nutrition Research...Completed
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI)CompletedMetabolic Syndrome | Insulin Resistance | DyslipidemiaUnited States
-
NovartisCompletedDyslipidemiaGermany, Switzerland
-
Organon and CoCompleted
-
Gary Van GuilderWestern Colorado University; Auckland University of TechnologyActive, not recruitingMetabolic Syndrome | Insulin Resistance | Endothelial Dysfunction | Atherogenic DyslipidemiaUnited States
-
GlaxoSmithKlineTerminatedHeart Failure | DyslipidaemiasUnited States
-
GlaxoSmithKlineCompletedAn Exploratory Study To Look At The Effect Of Two Investigational Drugs On Body Fat And InflammationObesity | Hypercholesterolemia | DyslipidaemiasUnited States
-
Hanlim Pharm. Co., Ltd.RecruitingMixed DyslipidemiaKorea, Republic of